Skip to content

reGional Network for Acute Myocardial Infarction

Construction of Modern reGional Network for Acute Myocardial Infarction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03928119
Acronym
GAMI
Enrollment
7102
Registered
2019-04-25
Start date
2015-08-01
Completion date
2024-02-28
Last updated
2022-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Coronary Heart Disease, STEMI - ST Elevation Myocardial Infarction

Keywords

Acute myocardial infarction, STEMI, regional network

Brief summary

Incidence of ST-segment Elevation Myocardial Infarction (STEMI) is rising and the existing emergency medical aid system for STEMI was not enough for timely perfusion treatment. No existing research with high-quality data focuses on the characteristic of STEMI incidence and regional network construction. Aiming of Guangdong GAMI(reGional network for Acute Myocardial Infarction) project is to establish effective collaborative regional network system for STEMI patients treatment.

Detailed description

The project of Guangdong GAMI(reGional network for Acute Myocardial Infarction) is being conducted during 2015-2019 in eight districts with diverse economic development across southern China (Integrated care model was conducted in four regions, which mainly included community public education, non primary-PCI capable centre and referral system improvement, and inhospital green-channal optimization for primary-PCI capable centre. Other four centers were underwent usual care of acute myocardial infacrtion public and medical health service). All the ST-segment elevation myocardial infarction (STEMI) patients admitted in the hospital within 30 days from the symptom onset were enrolled. The key data of the timeline of STEMI onset and treatment were precisely recorded. Other details of STEMI treatment in hospitals such as laboratory data and medication were also collected. During the research period, actions of both optimizing the regional STEMI patients transfer and treatment to shorten the medical delay, as well as educating the public to improve their awareness of early treatment of STEMI were taken meanwhile. In addition, laboratory data, medication, and follow-up information were recorded in a database for further analysis regarding the STEMI patient treatment.

Interventions

BEHAVIORALpublic education and network construction

Publication education includes multiple methods of acute myocardial infarction knowledge education. Network construction includes regional connection of ST-Segment Elevation Myocardial Infarction patients transfer for percutaneous coronary intervention treatment, as well as physicians skill improvement in primary hospital.

Sponsors

Maoming People's Hospital
CollaboratorOTHER
Dongguan People's Hospital
CollaboratorOTHER_GOV
Southern Medical University, China
CollaboratorOTHER
Guangzhou Panyu Central Hospital
CollaboratorOTHER
Yangjiang People's Hospital
CollaboratorOTHER
Shenzhen People's Hospital
CollaboratorOTHER
Longyan First Hospital, Affiliated to Fujian Medical University
CollaboratorUNKNOWN
Guangdong Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All adult patients who suspected diagnosis with STEMI.

Exclusion criteria

1. patients refused to undergo coronary angiography; 2. patients were confirmed as non-STEMI by coronary angiography or the course of STEMI over 1 month; 3. patients occurred onset STEMI during hospitalization in hospitals

Design outcomes

Primary

MeasureTime frameDescription
Receipt of reperfusion therapy within 12 hoursInfarction patientsFrom 1 month before hospitalization to 24 hours after hospitalizationThe primary outcome was the proportion of patients who received symptom-to-reperfusion treatment within 12 hours.

Secondary

MeasureTime frameDescription
Onset-to-admission time within 12 hoursFrom 1 month before hospitalization to 24 hours after hospitalizationThe proportion of patients who take a symptom-to-admission period within 12 hours.
Door-to-balloon time within 90 minutes24 hoursThe proportion of patients who take a door-to-balloon period within 90 minutes.
In-hospital clinical outcomes30 daysThe incidence of several in-hospital outcomes (in-hospital death; and major adverse cardiac events \[MACEs\], which mainly included in-hospital death, recurrence of myocardial infarction, and stroke); the length of stay.
1-year all-cause mortality1 yearTotal mortality between 30 days and 1 year after discharge.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026